拟定邀请嘉宾(Invited Speakers):

●      Michael R. De Felippis, Ph.D.
        USA Chair, USP BIO1 - Peptides and Insulins Expert Committee
●      Michael Huang, Ph.D.
        Senior Science and Standards Liaison, Global Biologics, USP. USA
        Primary Liaison, USP BIO1 - Peptides and Insulins Expert Committee
●      FDA
●      CFDA/ChP/NIFDC
●      Industry/Institution/Association

 

议题(Session):

议题一:合成多肽药物的药典标准及更新
Session 1
Compendial standards and program updates for therapeutic synthetic peptides

议题二:合成多肽药物的GMP生产与法规
Session 2
GMP manufacturing and regulations

议题三:多肽药物及其相关杂质的分析表征与质控技术
Session 3
Analytical techniques for peptide characterization, impurities and quality control

议题四:多肽药物在中国的前景与机遇
Session 4
Development and opportunities of therapeutic peptides in China